Borillo, Janiva U.
HRN: 29-17-37 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2026
CEFTRIAXONE 1G (VIAL)
06/18/2026
06/25/2026
IVTT
2g
OD
CAP-MR
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: